286 related articles for article (PubMed ID: 29191716)
1. Pulmonary absorption - estimation of effective pulmonary permeability and tissue retention of ten drugs using an ex vivo rat model and computational analysis.
Eriksson J; Sjögren E; Thörn H; Rubin K; Bäckman P; Lennernäs H
Eur J Pharm Biopharm; 2018 Mar; 124():1-12. PubMed ID: 29191716
[TBL] [Abstract][Full Text] [Related]
2. Development of a Novel Quantitative Structure-Activity Relationship Model to Accurately Predict Pulmonary Absorption and Replace Routine Use of the Isolated Perfused Respiring Rat Lung Model.
Edwards CD; Luscombe C; Eddershaw P; Hessel EM
Pharm Res; 2016 Nov; 33(11):2604-16. PubMed ID: 27401409
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary absorption rate and bioavailability of drugs in vivo in rats: structure-absorption relationships and physicochemical profiling of inhaled drugs.
Tronde A; Nordén B; Marchner H; Wendel AK; Lennernäs H; Bengtsson UH
J Pharm Sci; 2003 Jun; 92(6):1216-33. PubMed ID: 12761811
[TBL] [Abstract][Full Text] [Related]
4. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
5. Drug absorption from the isolated perfused rat lung--correlations with drug physicochemical properties and epithelial permeability.
Tronde A; Nordén B; Jeppsson AB; Brunmark P; Nilsson E; Lennernäs H; Bengtsson UH
J Drug Target; 2003 Jan; 11(1):61-74. PubMed ID: 12852442
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Dissolution of Poorly Soluble Compounds Studied in an ex Vivo Rat Lung Model.
Eriksson J; Thörn H; Sjögren E; Holmstén L; Rubin K; Lennernäs H
Mol Pharm; 2019 Jul; 16(7):3053-3064. PubMed ID: 31136181
[TBL] [Abstract][Full Text] [Related]
7. Advances in experimental and mechanistic computational models to understand pulmonary exposure to inhaled drugs.
Bäckman P; Arora S; Couet W; Forbes B; de Kruijf W; Paudel A
Eur J Pharm Sci; 2018 Feb; 113():41-52. PubMed ID: 29079338
[TBL] [Abstract][Full Text] [Related]
8. A Comparison of Drug Transport in Pulmonary Absorption Models: Isolated Perfused rat Lungs, Respiratory Epithelial Cell Lines and Primary Cell Culture.
Bosquillon C; Madlova M; Patel N; Clear N; Forbes B
Pharm Res; 2017 Dec; 34(12):2532-2540. PubMed ID: 28924829
[TBL] [Abstract][Full Text] [Related]
9. Translocation of gold nanoparticles across the lung epithelial tissue barrier: Combining in vitro and in silico methods to substitute in vivo experiments.
Bachler G; Losert S; Umehara Y; von Goetz N; Rodriguez-Lorenzo L; Petri-Fink A; Rothen-Rutishauser B; Hungerbuehler K
Part Fibre Toxicol; 2015 Jun; 12():18. PubMed ID: 26116549
[TBL] [Abstract][Full Text] [Related]
10. Multitask learning for predicting pulmonary absorption of chemicals.
Chiu YW; Tung CW; Wang CC
Food Chem Toxicol; 2024 Mar; 185():114453. PubMed ID: 38244667
[TBL] [Abstract][Full Text] [Related]
11. One (sub-)acinus for all: Fate of inhaled aerosols in heterogeneous pulmonary acinar structures.
Hofemeier P; Koshiyama K; Wada S; Sznitman J
Eur J Pharm Sci; 2018 Feb; 113():53-63. PubMed ID: 28954217
[TBL] [Abstract][Full Text] [Related]
12. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery.
Sakagami M
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1030-60. PubMed ID: 17010473
[TBL] [Abstract][Full Text] [Related]
13. In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals.
Nahar K; Gupta N; Gauvin R; Absar S; Patel B; Gupta V; Khademhosseini A; Ahsan F
Eur J Pharm Sci; 2013 Aug; 49(5):805-18. PubMed ID: 23797056
[TBL] [Abstract][Full Text] [Related]
14. Uncovering the regional localization of inhaled salmeterol retention in the lung.
Bäckström E; Hamm G; Nilsson A; Fihn BM; Strittmatter N; Andrén P; Goodwin RJA; Fridén M
Drug Deliv; 2018 Nov; 25(1):838-845. PubMed ID: 29587546
[TBL] [Abstract][Full Text] [Related]
15. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary drug absorption and systemic exposure in human: Predictions using physiologically based biopharmaceutics modeling.
Eriksson J; Thörn H; Lennernäs H; Sjögren E
Eur J Pharm Biopharm; 2020 Nov; 156():191-202. PubMed ID: 32941997
[TBL] [Abstract][Full Text] [Related]
17. Across the pulmonary epithelial barrier: Integration of physicochemical properties and human cell models to study pulmonary drug formulations.
Haghi M; Ong HX; Traini D; Young P
Pharmacol Ther; 2014 Dec; 144(3):235-52. PubMed ID: 24836727
[TBL] [Abstract][Full Text] [Related]
18. Investigating drug absorption from the colon: Single-pass vs. Doluisio approaches to in-situ rat large-intestinal perfusion.
Lozoya-Agullo I; Zur M; Fine-Shamir N; Markovic M; Cohen Y; Porat D; González-Álvarez I; González-Álvarez M; Merino-Sanjuán M; Bermejo M; Dahan A
Int J Pharm; 2017 Jul; 527(1-2):135-141. PubMed ID: 28501438
[TBL] [Abstract][Full Text] [Related]
19. In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation.
Ong HX; Benaouda F; Traini D; Cipolla D; Gonda I; Bebawy M; Forbes B; Young PM
Eur J Pharm Biopharm; 2014 Jan; 86(1):83-9. PubMed ID: 23851077
[TBL] [Abstract][Full Text] [Related]
20. Drug permeability in 16HBE14o- airway cell layers correlates with absorption from the isolated perfused rat lung.
Manford F; Tronde A; Jeppsson AB; Patel N; Johansson F; Forbes B
Eur J Pharm Sci; 2005 Dec; 26(5):414-20. PubMed ID: 16153810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
